S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
Log in

Sarepta Therapeutics Price Target & Analyst Ratings (NASDAQ:SRPT)

$112.39
-1.29 (-1.13 %)
(As of 01/24/2020 04:00 PM ET)
Today's Range
$110.42
Now: $112.39
$115.55
50-Day Range
$100.48
MA: $125.42
$135.63
52-Week Range
$72.05
Now: $112.39
$158.80
Volume787,786 shs
Average Volume1.05 million shs
Market Capitalization$8.38 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.27

Analyst Ratings

Sarepta Therapeutics (NASDAQ:SRPT) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
24 Wall Street analysts have issued ratings and price targets for Sarepta Therapeutics in the last 12 months. Their average twelve-month price target is $201.20, suggesting that the stock has a possible upside of 79.02%. The high price target for SRPT is $270.00 and the low price target for SRPT is $170.00. There are currently 1 hold rating and 23 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.962.962.953.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
23 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
23 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
19 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
18 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $201.20$201.30$192.69$211.63
Price Target Upside: 79.02% upside49.89% upside130.82% upside42.36% upside

Sarepta Therapeutics (NASDAQ:SRPT) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Sarepta Therapeutics (NASDAQ:SRPT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/23/2020Leerink SwannReiterated RatingBuy$216.00Low
1/14/2020Credit Suisse GroupReiterated RatingBuy$185.00Low
1/14/2020CowenReiterated RatingBuy$213.00High
1/7/2020Bank of AmericaReiterated RatingBuy$187.00High
12/30/2019OppenheimerReiterated RatingHoldLow
12/26/2019CitigroupReiterated RatingBuy$177.00Low
12/25/2019NomuraReiterated RatingBuy$230.00Low
12/24/2019Goldman Sachs GroupReiterated RatingBuy$180.00Low
12/24/2019Morgan StanleyBoost Price TargetOverweight$160.00 ➝ $173.00Low
12/23/2019Piper Jaffray CompaniesReiterated RatingBuy$210.00N/A
12/23/2019Royal Bank of CanadaLower Price TargetOutperform$215.00 ➝ $200.00Medium
12/20/2019Robert W. BairdBoost Price TargetOutperform$181.00 ➝ $192.00Low
12/15/2019BarclaysReiterated RatingBuy$202.00Medium
12/13/2019HC WainwrightBoost Price Target$160.00 ➝ $260.00Low
12/13/2019Cantor FitzgeraldBoost Price TargetOverweight$175.00 ➝ $211.00High
12/13/2019Janney Montgomery ScottBoost Price TargetBuy$160.00 ➝ $175.00High
11/1/2019GuggenheimInitiated CoverageBuy$183.00High
8/21/2019Needham & Company LLCLower Price TargetBuy$196.00 ➝ $170.00Low
8/9/2019William BlairReiterated RatingBuyLow
8/8/2019Evercore ISIReiterated RatingBuy$200.00High
4/17/2019BTIG ResearchSet Price TargetBuy$190.00High
3/12/2019BMO Capital MarketsInitiated CoverageOutperformLow
3/5/2019Svb LeerinkReiterated RatingOutperformLow
2/27/2019JMP SecuritiesReiterated RatingBuy$270.00High
10/12/2018Sanford C. BernsteinInitiated CoverageOutperform$170.00High
6/22/2018SunTrust BanksBoost Price TargetBuy$176.00High
6/20/2018WBB SecuritiesReiterated RatingBuyLow
6/19/2018JPMorgan Chase & Co.Reiterated RatingOverweightHigh
5/4/2018UBS GroupDowngradeOutperform ➝ Market PerformHigh
(Data available from 1/24/2018 forward)
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Featured Article: What is a back-end load?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel